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Abstract 
Mutations in the GJB2 gene at the DFNB1 locus on chromosome 13q12 are associated with autosomal recessive non syndromic hearing loss (ARNSHL) in 
many populations. A single mutation, at position 35 (35delG) accounts for approximately 30-63% of mutations in white populations with a carrier 
frequency of 1.5-2.5% in most European, North American and Mediterranean populations. In this study we have investigated the prevalence of the GJB2 
gene mutations using direct sequencing in 43 presumed ARNSHL subjects from 34 families in an Iranian population. Eleven different genetic variants 
were identified. GJB2-related deafness mutations (35delG, 235delC, W24X, R184P and IVS1+1G>A) were found in 9 of 34 families (26.5%). The 35delG 
was the most common mutation found in 5 of 34 families (14.7%). We found one novel variant (–3517G>A) in the upstream region to the gene. The 
mutation frequency found in this study is lower than other ethnic groups with European ancestry, but it is indicating that mutation in GJB2 in Iranian 
population has contribution to ARNSHL. We have also developed a simple and accurate nested PCR assay to screen the 35delG mutation in 250 unrelated 
unaffected Iranian individual (controls). No 35delG heterozygous was found in the control population. 
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INTRODUCTION  
 
Congenital deafness is a frequent disorder that affects 1 in 1000 
neonates of which 50% is the result of genetic factors (15, 17). 
About 80% of the hereditary deafness cases are non-syndromic 
and are inherited in an autosomal recessive mode (25). 
Mutations in the connexin 26 (GJB2) genes (GJB2; MIM# 
121011) at the DFNB1 locus (DFNB1; MIM#220290) on 
chromosome 13q12 are associated with ARNSHL in many 
populations (6, 10, 16). A single mutation, at position 35 
(35delG), accounts for approximately 30-63% of mutations in 
white populations with a carrier frequency of 1.5-2.5% in most 
European, North American and Mediterranean populations (7, 
8, 10, 11). The 35delG mutation is less frequent or even absent 
in other ethnic groups with other common mutations prevailing 
such as 235delC in the Japanese and Korean (1, 13, 20) 
167delT in the Ashkenazi Jews (16, 26) and R143W mutation 
in an African village (4). In the present study we have identified 
the spectrum and prevalence of connexin 26 mutations using 
direct sequencing technique of both coding and non-coding 
exons of this gene. We have also developed a simple and 
accurate method to screen the Iranian population for the 35delG 
mutation.  
                                    
                                                  
MATERIALS and METHODS 
Two groups of individual containing 250 anonymous blood 
donors (controls) and 43 patients with presumed ARNSHL 
from 34 families were studied. Medical history and pedigree 
information were obtained by a questionnaire. The patients 
were students attending a school for hearing-impaired in Tehran 
and their siblings between age of 3 to 32 (mean: 14.5 years). 
All parents had normal hearing with one or more affected 
children. There was no evidence of any obvious syndrome or 
dominant family history. All patients had mild to profound 
sensorineural hearing loss. A relatively high level of 
consanguinity (73%) was seen in the families studied. All the 
families were informed and consent was obtained in all cases. 
Blood samples from patients and controls were prepared in 
dried blood spots. DNA was extracted following a standard 
phenol chloroform procedure. Control genomic DNA samples 
containing the 35delG mutation were kindly provided by Rohan 
Taylor (S. W. Thames Regional Genetic Services). Using a 
nested PCR procedure, the one base pair deletions of 35delG 
were screened in 250 controls and all the members of 34 
patient’s families. The entire coding sequence of cx26 gene 
(Genbank accesion#M86849) was amplified using primers 
CX148F2 5’CCTGTGTTGTGTGCATTCGTC3’ / CX929R3 
5’CTCATCCCTCTCATGCTGTC3’ (782 bp) at an annealing 
temperature of 59ºC. The amplified product was then diluted 
and used as a template for a second round of PCR using primers 
CX210F4 5’CACGCTGCAGACGATCC3’ / CX252R4 
5’GGTGGAGTGTTTGTTCAC3’(43 bp) at an annealing 
temperature of 54ºC. The amplified products were then 
separated by electrophoresis on a 15% Polyacrylamide gel 
(40% 19:1 Acrylamide: Bisacrylamide) at 35 mA for 2:30 hours 
and the products were then visualised by silver staining. The 
35delG mutations were detected by identification of two 
separate bands of 43 bp for the wild type and 42 bp for the 
mutant allele. Two sets of primers were used to produce the 
template for sequencing in both coding and non-coding 
(Genbank accesion#U43932) regions. The first pair of primers 
CX148F2 / CX929R3 (as described above) was used to amplify 
the entire coding region of the gene. The second pair of primer 
CX1197F1 5’AGGCGGCGCTCGGGGTAAC3’ / CX1679R1 
5’TCCCCGCGCCAGGTTCCTG3’ (483 bp) was used to 
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amplify the non-coding, the flanking donor splicing site and 
upstream region to the gene at annealing temperature of 64ºC. 
The same primers were used for sequencing of the gene in both 
directions. In addition two internal primers CX586R2 
5’CTTCGATGCGGACCTTCTGG3’ and CX482F3 
5’TGGCCTACCGGAGACATGAG3’ were used for 
sequencing of the coding region. Sequencing was carried out 





The initial screening using a nested PCR found no 35delG 
heterozygous mutation in the control subjects, but identified 
this mutation in 5 out of 34 ARNSHL families studied. All of 
the detected 35delG mutations then were confirmed by 
sequencing. To investigate other mutations in the GJB2 gene, 
sequencing of the whole coding and non-coding region of the 
gene was carried out and altogether 11 different genetic variants 
were identified (Table 1). All of these variants except -
3517G>A (Fig. 1) have been described elsewhere (21, 24). 
GJB2-related deafness mutations (35delG, 235delC, W24X, 
R184P and IVS1+1G>A) were found in 9 ARNSHL families 
(26.5%). Three GJB2-related deafness mutations including 
35delG, 235delC and R184P were homozygous in 7 families 
(20.6%). The homozygous 35delG was the most common 
mutation accounting for 55.5% of all GJB2-related deafness 





Figure 1. Nucleotide sequence of the novel variant                
(-3517G>A) compare to control. 
 
genetic variant with unknown relation to the deafness (M163V) 
and four polymorphisms (V153I, S86T, R127H, and –
3558T>C) were found in this study. We also found one novel 
variant (–3517G>A) in upstream region to the gene. Eight 
samples of the control population fully sequenced. All showed 
S86T variant, 37.5% (3/8) showed -3558T>C variant and 
12.5% (1/8) showed the –3517G>A variant.  
 
 
Table 1 Genetic variants in the GJB2 gene identified in Iranian ARNSHL families 
 
aSecond variant identified in other allele of cx26 at least in one  atient. 











Name of variant Nucleotide change Second varianta Chromosome n (%)b Family No 
-3558T>C T to C at –3558 Yes 21(31) 15 
-3517G>A G to A at –3517 Yes 4(6) 3 
IVS1+1G>A G to A at +1 from exon 1 No 1(1.5) 1 
35delG Deletion of G at 35 Yes 10 (15) 5 
W24X G to A at 71 No 1(1.5) 1 
235delC Deletion of C at 235 Yes 2(3) 1 
S86T GC to CG at 257-8 Yes 68 (100) 34 
R127H G to A at 380 No 1(1.5) 1 
V153I G to A at 457 Yes 6(9) 5 
M163V A to G at 487 Yes 2(3) 1 
R184P G to C at 551 Yes 2(3) 1 





We have developed a nested PCR to determine the frequency of 
35delG mutation in Iranian population. Using this procedure 
both the mutant (42 bp) and wild type (43bp) alleles were 
separated and visualised in a polyacrylamide gel. The 35delG 
mutation is a deletion of a single guanine residue within a 
stretch of six  Guanines between nucleotide position of 30-35 in 
the coding region of GJB2 gene. The 43-bp sequence of the 
nested PCR containing a stretch of eight nucleotides 
(TGGGGGGT) in the position of 29-36 between the position of 
two forward and reverse primers. Using nested PCR, 35delG 
mutation was detected in the stretch of six Gs plus two flanking 
Ts. It means that, the deletion of the flanking T in the stretch of 
eight nucleotides (TGGGGGGT) can be mistaken with the 
35delG mutation and decreases the specificity of the method. 
However, no 29delT and 36delT have been reported so far. The 
same stretch of 8 nucleotides has been used as a target sequence 
for PCR-mediated site-directed mutagenesis followed by BsiYI 
digestion to detect the 35delG mutation (27). We found the 
nested PCR suitable to detect 35delG in different source of 
DNA particularly spotted blood (data not shown). The 
sensitivity of the nested PCR method is also very high (14) and 
there is no probability of missing a mutation due to non 
amplification. However, we found nested PCR a very accurate 
and reliable method to detect the 35delG mutation and may find 
widespread use in DNA diagnostics of ARNSHL subjects. This 
screening method determined 35delG mutation in 5 families 
(14.7%) and all were confirmed by direct sequencing.  
Mutation in 35delG is responsible for 10% of all childhood 
hearing loss and for 20% of all childhood hereditary hearing 
loss in Caucasian American originated from northern and 
southern Europe (12). Our finding represented a lower rate of 
35delG mutations. No 35delG heterozygote carriers were 
identified in the control group of 250 blood donors. A low 
frequency or absence of the 35delG carriers have been reported 
in Omani, Pakistani, Turkish, British Asian, Palestinian and 
Japanese populations (1, 3, 5, 22, 23, 24 ). The rare carrier 
frequency of 35delG could be due to the decreased prevalence 
of this mutation outside the European ancestry and the 
contribution of other mutations depending on the ethnic origins. 
It could be also due to ascertainment and relatively small size of 
the control population studied. 
Eleven different genetic variants were identified, all of which, 
except (–3517G>A) have been described previously. Among 
them the GJB2-related deafness mutations have been 
determined as 35delG, 235delC, W24X, R184P and 
IVS1+1G>A. Also four polymorphisms (V153I, S86T, R127H, 
and –3558T>C) and one variant with unknown relation to the 
deafness (M163V) were determined in this study. We also 
found one novel variant (–3517G>A) in the upstream region to 
the gene. The -3517G>A variant was found in 1 of 8 controls 
studied and comparing this variant with Genbank (2). The same 
sequence was found in ref / NT_009917.8 / Hs13_10074 which 
makes it likely to be a polymorphism in this nucleotide 
position.    
Najmabadi and coworkers have recently analysed GJB2 gene 
mutations in 168 Iranian ARNSHL subjects from 83 families. 
They used an allele-specific PCR to screen the 35delG and pre 
screening method of SSCP followed by sequencing to screen 
the other variants in the GJB2 gene. They found 9 different 
variants and 9 of 83 families (11%) with homozygous and 
compound heterozygous GJB2-related deafness mutations. 
They identified 55% of homozygosity in GJB2-related deafness 
mutations (19). Using a direct sequencing strategy in the 
present study, we found a higher rate of 11 variants and 7 0f 34 
families (20.6%) with homozygous GJB2-related deafness 
mutations. Our study identified 60% of homozygosity in GJB2-
related deafness mutations. The high level of homozygosity in 
this study could be due to the consanguinity or ascertainment in 
the population studied. The present study was carried out on a 
population with consanguinity of 73%. This rate of 
consanguinity is relatively high, compare to the rate of 37.3% 
consanguinity reported in the Iranian population (9). However 
no data of consanguinity has been given by Najmabadi and 
coworkers.  
The frequency of congenital deafness is 1 in 1000 neonates of 
which 50% is the result of genetic factors (15, 17) and about 
80% of the hereditary deafness cases are recessive non-
syndromic (25). Our finding indicated GJB2-related deafness in 
9 of 34   ARNSHL families (26.5%). These data suggest that 
about 13% of all congenital hearing loss is caused by mutation 
in GJB2. The contribution of the GJB2 gene in ARNSHL in 
Iran (26.5) is lower than many populations studied, such as 
33% in Lebonon (18) 40% in USA (12) and 49% in Italy and 
Spain (8). However, it is indicated that mutations in GJB2 in 
Iranian population contribute to recessively inherit non-
syndromic hearing loss. The reason of deafness for the 
remaining 73.5% ARNSHL families in Iran remains to be 
studied. The Iranian population is composed of several ethnic 
groups and more work on the ethnic population basis is needed. 
Finally, since there is a contribution of mutation in GJB2 in 
Iranian population, screening of the GJB2 mutations 
particularly 35delG can be offered to individuals with 
congenital deafness.  
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